发明名称 Base modified oligonucleotides
摘要 The present invention relates to oligonucleotides with base modified nucleosides for enhancement of binding affinity.
申请公布号 US9416360(B2) 申请公布日期 2016.08.16
申请号 US201113883363 申请日期 2011.11.07
申请人 miRagen Therapeutics, Inc. 发明人 Vagle Kurt;Dalby Christina;Marshall William S.
分类号 C12N15/113;C12N15/11 主分类号 C12N15/113
代理机构 Cooley LLP 代理人 Cooley LLP
主权项 1. A base modified antisense oligonucleotide, comprising: at least one nucleotide having both: a) a 2′ modification; and b) an amino carbonyl base modification at the C-5 position of a pyrimidine base, wherein the oligonucleotide is from about 5 to about 25 nucleotides in length and contains one or more phosphorothioate linkages; and wherein the 2′ modification is 2′-OMe and the amino carbonyl modified pyrimidine base has the following structure: wherein R is at least one member selected from the group consisting of:
地址 Boulder CO US